TEMPEST THERAPEUTICS INC (TPST)

US87978U1088 - Common Stock

0.95  0 (-0.2%)

After market: 0.95 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
35.62M29.16M34.64M26.99M35.97M
Research and Development
21.92M17.50M22.53M17.17M20.37M
Selling, General, and Administrative Expenses
13.70M11.66M12.11M9.82M15.60M
Operating Income
-35.62M-29.16M-34.64M-26.99M-35.97M
Interest Income/Expense
103.00K-334.00K-1.62M-1.28M160.00K
Other Income/Expense
N/AN/A550.00K-30.00K-590.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-35.52M-29.49M-35.71M-28.30M-36.41M
Income Tax
N/A0.000.00N/AN/A
Net Income
-35.52M-29.49M-35.71M-28.30M-36.41M
EBITDA
-35.20M-28.78M-34.00M-26.62M-35.82M
 
Per Share Data
EPS Diluted Total Ops
-1.57-1.91-3.09-7.47-28.89
Non GAAP EPS
-1.57-1.95-3.26-16.56-29.10
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts